Specialty Drug

Generic Copaxone

Glatopa (glatiramer acetate) is an immunomodulator used to reduce the frequency of relapses in patients with multiple sclerosis (MS). It is not an interferon, but may be grouped with interferon betas Avonex and Betaseron; together the three first-line treatments are sometimes known as the "ABC" drugs for MS. The exact mechanism of action of glatiramer in patients with MS is unknown. Compare interferon betas.

Glatopa Latest News

Get the latest updates on this drug from the GoodRx medical team

2015 In Review: The Good(Rx) and Bad

Elizabeth Davis - December 29, 2015

2015 was another tough year for American’s health care budgets. Insurance premiums increased, coverage was dropped for a number of important drugs, and overall we’re spending more for our health care.

Don’t break out the antidepressants yet—it’s not all bad news. A number of important drugs went generic, which will generally mean huge savings and lower costs. Plus, a large number of drugs actually decreased in price. See More

New Copaxone Generic Launched! Look for Glatopa in Pharmacies Soon

The GoodRx Pharmacist - June 26, 2015

Glatopa, the new generic alternative to multiple sclerosis (MS) treatment Copaxone, was approved earlier this year, and its launch has been anxiously awaited. Now, the time has come, and Glatopa will be available in pharmacies soon!

Manufacturer Sandoz announced last Thursday, June 18, that Glatopa has began shipping following its recent FDA approval.

Is Glatopa an FDA approved generic?

Yes. Glatopa has been approved by the FDA as a substitutable generic for the brand-name drug CopaxoneSee More

New Copaxone Generic Now Approved: Glatopa May Reduce Treatment Costs

The GoodRx Pharmacist - May 01, 2015

Multiple sclerosis (MS) is a debilitating autoimmune disease that currently does not have a cure. It affects around 400,000 people in the United States alone, with symptoms presenting most often between 20 and 40 years of age.

Copaxone (glatiramer acetate), one of the most popular treatments for multiple sclerosis, has recently received generic FDA approval under the name Glatopa.

The FDA approval of Glatopa is a big deal for patients being treated for MS, especially since medication costs for this condition are nearing $60,000 a year. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.